| | | | |

Mesothelioma Subtypes Often Misclassified by Biopsy

mesothelioma subtypes Pleural biopsy is not perfect when it comes to telling the difference between the three mesothelioma subtypes. But misclassification could lead to shorter survival. 

That is the conclusion reached by top mesothelioma researchers in Brescia, Italy. 

They compared autopsy records from 134 Italian mesothelioma patients. The patients were either shipyard workers or their spouses. The researchers found that the mesothelioma subtypes identified from biopsy tissue were incorrect a large percent of the time.

Misclassification matters because it impacts which mesothelioma treatments doctors choose. 

The Three Mesothelioma Subtypes

Pleural mesothelioma is an aggressive malignancy on the lung lining. It is caused by exposure to asbestos. Mesothelioma cells fall into three mesothelioma subtypes based on certain cellular characteristics. Pleural mesothelioma is notoriously difficult to treat with standard therapies. Getting the subtype right is critical for choosing the most effective treatment.

Epithelioid mesothelioma is the most common of the three mesothelioma subtypes. About half of pleural mesothelioma patients have this type. This subtype has the best response to surgery. People with epithelioid mesothelioma tend to have the best prognosis.  

About 20 percent of mesothelioma patients have sarcomatoid mesothelioma. Sarcomatoid cells are more spindle-shaped than epithelioid cells. Sarcomatoid mesothelioma is the hardest of the three mesothelioma subtypes to treat. 

Thirty percent of mesothelioma patients have both epithelioid and sarcomatoid cells in their tumors. This is biphasic mesothelioma. Like sarcomatoid, it is very hard to treat. People with sarcomatoid or biphasic mesothelioma are not good candidates for surgery. 

Pleural Biopsies Do Not Tell The Whole Story

The goal of the new Italian study was to test the accuracy of diagnoses made from pleural biopsy. Surgeons collected cells using either video-assisted thoracoscopic surgery (VATS) or surgery. They made a diagnosis and planned treatment based on their conclusions.

Those conclusions were checked against necropsy data collected after each patient died. 

Necrosy showed a breakdown of the three mesothelioma subtypes as follows: 62 epithelioid, 51 biphasic, and 21 sarcomatoid. Three quarters of the biphasic cases  had been classified as epithelioid when the patients were alive. 

The researchers found that cells obtained during either VATS or open surgery were good for correctly identifying epithelioid mesothelioma. But they were not as good at diagnosing the other two mesothelioma subtypes. 

“We observed a substantial degree of misclassification between epithelioid and biphasic MPM for pleural biopsies performed during VATS,” writes researcher Pietro Gino Barbieri in the Italian journal Tumori. “We also observed substantial misclassification of biospecimens collected during MPM surgery.”

Previous studies show that surgery can be a good treatment for epithelioid mesothelioma. But surgery is not recommended for patients with other mesothelioma subtypes.

The research team concludes that “caution should be taken” in using VATS-obtained data to choose patients for mesothelioma surgery.

Source:

Barbieri, PG, et al, “Accuracy of pleural biopsy for the diagnosis of histologic subtype of malignant pleural mesothelioma: Necropsy-based study of 134 cases”, March 15, 2021, Tumori, Online ahead of print, https://journals.sagepub.com/doi/10.1177/0300891620988354

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…